Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Many patients in the rheumatology clinic adjusted or stopped their medications due to side effects.

Cyproterone acetate is used for topical treatment of diseases dependent on male hormones.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

Baricitinib is effective as a treatment for severe hair loss.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Baricitinib is effective and safe for treating severe alopecia areata.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Azole antifungals can cause skin reactions like EAC, requiring careful management.

PEA-ENL improves skin delivery and reduces inflammation without side effects.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Topical immunotherapy is more effective than dapsone for treating severe alopecia areata.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Oral tofacitinib is more effective than oral minoxidil for treating alopecia areata.